|
ZFAND1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
1.5323999846828E-09 |
| Normal-vs-Stage3 |
1.11022302462516E-16 |
| Normal-vs-Stage4 |
2.39785968858541E-12 |
| Stage1-vs-Stage2 |
8.123400E-01 |
| Stage1-vs-Stage3 |
5.823700E-02 |
| Stage1-vs-Stage4 |
1.932570E-01 |
| Stage2-vs-Stage3 |
3.013200E-01 |
| Stage2-vs-Stage4 |
4.124400E-01 |
| Stage3-vs-Stage4 |
8.816200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
2.35779999999686E-05 |
| Normal-vs-Asian |
4.50284254327471E-12 |
| Caucasian-vs-AfricanAmerican |
1.541170E-01 |
| Caucasian-vs-Asian |
6.967200E-01 |
| AfricanAmerican-vs-Asian |
1.250210E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
8.416400E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.63002944475465E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.64934732538313E-12 |
| Normal-vs-Age(81-100Yrs) |
1.609240E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.664800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.818000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.228200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.237400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.754800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.039800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.375900E-02 |
| Classical-VS-Follicular |
3.954200E-02 |
| Classical-VS-Other |
8.736800E-01 |
| Classical-VS-Normal |
8.90842954959226E-13 |
| Tall-VS-Follicular |
2.339300E-03 |
| Tall-VS-Other |
2.876200E-01 |
| Tall-VS-Normal |
4.16444656536896E-13 |
| Follicular-VS-Other |
5.954400E-01 |
| Follicular-VS-Normal |
5.30869999959549E-07 |
| Other-VS-Normal |
2.162400E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.4432899320127E-15 |
| Normal-vs-N1 |
1.25455201782643E-13 |
| N0-vs-N1 |
1.624410E-01 |
|
|
